35 related articles for article (PubMed ID: 27132888)
1. Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.
Wen W; Zhang JP; Xu J; Su RJ; Neises A; Ji GZ; Yuan W; Cheng T; Zhang XB
Stem Cell Reports; 2016 Jun; 6(6):873-884. PubMed ID: 27161365
[TBL] [Abstract][Full Text] [Related]
2. Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy.
Wood GE; Bunting CP; Veli M; Arora R; Berney DM; Alifrangis C; MacDonald ND; Miller RE; Shamash J; Stoneham S; Lockley M
Front Oncol; 2023; 13():1271647. PubMed ID: 37954076
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis.
von Eyben FE; Kristiansen K; Kapp DS; Hu R; Preda O; Nogales FF
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835562
[TBL] [Abstract][Full Text] [Related]
4. The Master Regulator Protein BAZ2B Can Reprogram Human Hematopoietic Lineage-Committed Progenitors into a Multipotent State.
Arumugam K; Shin W; Schiavone V; Vlahos L; Tu X; Carnevali D; Kesner J; Paull EO; Romo N; Subramaniam P; Worley J; Tan X; Califano A; Cosma MP
Cell Rep; 2020 Dec; 33(10):108474. PubMed ID: 33296649
[TBL] [Abstract][Full Text] [Related]
5. The plasticity of germ cell cancers and its dependence on the cellular microenvironment.
Nettersheim D; Schorle H
J Cell Mol Med; 2017 Aug; 21(8):1463-1467. PubMed ID: 28244655
[TBL] [Abstract][Full Text] [Related]
6. Involvement of epigenetic modifiers in the pathogenesis of testicular dysgenesis and germ cell cancer.
Lawaetz AC; Almstrup K
Biomol Concepts; 2015 Jun; 6(3):219-27. PubMed ID: 26103631
[TBL] [Abstract][Full Text] [Related]
7. Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.
Jostes SV; Fellermeyer M; Arévalo L; Merges GE; Kristiansen G; Nettersheim D; Schorle H
Int J Cancer; 2020 Mar; 146(6):1592-1605. PubMed ID: 31583686
[TBL] [Abstract][Full Text] [Related]
8. SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate.
Nettersheim D; Heimsoeth A; Jostes S; Schneider S; Fellermeyer M; Hofmann A; Schorle H
Oncotarget; 2016 Jul; 7(30):47095-47110. PubMed ID: 27283990
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
Nonaka D
Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cells.
Nettersheim D; Westernströer B; Haas N; Leinhaas A; Brüstle O; Schlatt S; Schorle H
Genes Chromosomes Cancer; 2012 Jul; 51(7):717-26. PubMed ID: 22489004
[TBL] [Abstract][Full Text] [Related]
11. The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.
Nettersheim D; Gillis A; Biermann K; Looijenga LH; Schorle H
Genes Chromosomes Cancer; 2011 Dec; 50(12):1033-42. PubMed ID: 21987446
[TBL] [Abstract][Full Text] [Related]
12. Mechanism and Role of SOX2 Repression in Seminoma: Relevance to Human Germline Specification.
Kushwaha R; Jagadish N; Kustagi M; Mendiratta G; Seandel M; Soni R; Korkola JE; Thodima V; Califano A; Bosl GJ; Chaganti RSK
Stem Cell Reports; 2016 May; 6(5):772-783. PubMed ID: 27132888
[TBL] [Abstract][Full Text] [Related]
13. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
Looijenga LH
J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]